Antibodies that inhibit TSLP activity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 24, 2016
Grant Date -
Jan 1, 2015
app pub date -
Sep 16, 2014
filing date -
Nov 13, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention is directed to purified and isolated novel TSLP polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully